Browse EX-10 agreements

** **

STOCK PURCHASE AGREEMENT

(股权（股票）购买协议)

By and among:

SGLA, a Nevada corporation (“Purchaser”),

the equity holders of Invent Fortune (listed on Schedule 1.1) (each, a “Seller,” and collectively, the “Sellers”),

and Invent Fortune, a private limited company (Sendirian Berhad) organized under the laws of Malaysia, with its principal place of business in Semenyih, Selangor, Malaysia (the “Company”)

Date of Execution: 7 / AUG / 2026

…

---

Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of August 11, 2026, between Silexion Therapeutics Corp, a Cayman Islands corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.
DEFINITIONS

…

INTERNET SCIENCES INC.

ACTION BY WRITTEN CONSENT OF THE MAJORITY STOCKHOLDER

IN LIEU OF A SPECIAL MEETING OF STOCKHOLDERS

The undersigned, being the holder of a majority of the outstanding shares of voting stock of Internet Sciences Inc., a Delaware corporation (the “Company”), entitled to vote generally in the election of directors, acting pursuant to Section 228 of the General Corporation Law of the State of Delaware (“DGCL”), Section 141(k) of the DGCL, and Section 3.12 of the Company’s Amended and Restated Bylaws (the “Bylaws”), hereby adopts the following resolutions by written consent in lieu of a special meeting of stockholders, with the same force and effect as if adopted at a duly noticed and convened meeting of stockholders at which a quorum was present and voting:

…

STOCK TRANSFER AGREEMENT

This Stock Transfer Agreement (hereinafter the “Agreement”) is entered into as of July 30, 2026 (hereinafter the “Execution Date”) by and between the following parties:

1. Vestand Inc. (Address: 104 Apple Blossom Circle, Brea, CA 92821) (hereinafter the “Transferor”)

2. Noh Sang-woo (Address: 201-401 Healing M Town, 652-48 Sinhyeon-dong, Gwangju-si, Gyeonggi-do, Republic of Korea) (hereinafter the “Transferee”)

Where either the Transferor or the Transferee is referred to individually, such party is referred to as a “Party,” and collectively as the “Parties.”

PREAMBLE

Of the 200 shares of Vestand Korea Co., Ltd. held by the Transferor, the Transferor wishes to transfer to the Transferee 200 common shares of Vestand Korea Co., Ltd. (hereinafter the “Subject Shares”), and the Transferee wishes to acquire the Subject Shares from the Transferor. Accordingly, the Transferor and the Transferee hereby agree as follows with respect to the transfer of the Subject Shares.

Article 1 Purchase Price

…

ASSET PURCHASE AGREEMENT

** **

This Asset Purchase Agreement (this “Agreement”) is made as of August 7, 2026, by and between Aeternum Health, Inc., a Delaware corporation (the “Company”), and Manaslu LLC (“Seller”).

A. The Seller is the owner of an option to acquire a 50.1% stake in American Renaissance Materials LLC (“ARM”), and the Company desires to acquire this asset, which is more fully described in Appendix I to Exhibit A hereto (the “Assets”), in full consideration of which the Company will issue shares of its Series B preferred stock, par value $0.01 per share (“Preferred Stock”) and its shares of common stock, par value $0.01 per share (“Common Stock”) to the Seller.

B. Seller desires to sell to the Company the Assets for the equity consideration set forth in this Agreement.

NOW, THEREFORE, in consideration for the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

…

**EXECUTION VERSION **

**SECOND AMENDED AND RESTATED TERM LOAN AGREEMENT **

Dated as of August 7, 2026

by and among

EACH OF THE PERSONS SIGNATORY HERETO AND NAMED ON ANNEX A,

ALLY BANK

for itself as a Lender and as Administrative Agent for all Lenders,

and

THE OTHER FINANCIAL INSTITUTIONS PARTY HERETO AS LENDERS

---

**TABLE OF CONTENTS **

| | | | | | | | | | | ------------------------------------------------- | - | ---- | : | ----------------------------------------------- | - | :------: | -: | - | | | | | | | | | | | | | | | | | | Page | | | | | | | | | | | | |

…

**Exhibit 10.1 **

Execution Version

** **

VEEA INC.

Common Stock

($0.0001 par value per share)

** **

Sales Agreement

August 13, 2026

Roth Capital Partners, LLC

888 San Clemente Drive, Suite 400

Newport Beach, CA 92660

Ladies and Gentlemen:

Veea Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (the “Agent”), as follows:

1. Issuance and Sale of Shares. The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through or to the Agent, shares (the “Placement Shares”) of common stock of the Company, $0.0001 par value per share (the “Common Stock”), provided, however, that in no event shall the Company issue or sell through Agent such number of Placement Shares that (a) exceeds the number or dollar amount of shares of Common Stock that may be sold pursuant to the Registration Statement (as defined below), or (b) exceeds the number of authorized but unissued shares of Common Stock

…

**SPRINKLR, INC. **

**AMENDED AND RESTATED **

**NON-EMPLOYEE DIRECTOR COMPENSATION POLICY **

Each member of the Board of Directors (the “Board”) who is not also serving as an employee of or consultant to Sprinklr, Inc. (the “Company”) or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Amended and Restated Non-Employee Director Compensation Policy (this “Policy”) for his or her service on the Board.

An Eligible Director may decline all or a portion of their compensation by giving notice to the Company prior to the date on which quarterly cash payments are to be paid, or equity awards are to be granted, subject to compliance with applicable tax laws. This policy is effective as of May 27, 2026 (the “Effective Date”) and may be amended at any time by the Board or the Compensation Committee of the Board (the “Compensation Committee”).

**Annual Cash Compensation **

…

**SIXTH AMENDMENT TO **

**SECOND AMENDED AND RESTATED CREDIT AGREEMENT **

THIS SIXTH AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is entered into as of August 12, 2026 (the “Effective Date”), by and among WELLS FARGO CAPITAL FINANCE, LLC, a Delaware limited liability company, as a joint lead arranger and administrative agent (the “Agent”) for the Lenders (as defined in the Credit Agreement referred to below), the Lenders party hereto, WABASH NATIONAL CORPORATION, a Delaware corporation (“Wabash”), certain Subsidiaries of Wabash designated on the signature pages hereto as borrowers (together with Wabash, such Subsidiaries are collectively referred as the “Borrowers”) and certain Subsidiaries of Wabash designated on the signature pages hereto as guarantors. Capitalized terms not otherwise defined herein have the definitions provided therefor in the Credit Agreement (as hereinafter defined).

…

** **

Execution Version

Certain confidential portions have been redacted from this exhibit because they are both (i) not material and (ii) is the type that the company treats as private or confidential. Information that has been omitted had been identified in this document with a placeholder identified by the mark “[redacted]”.

FINANCIAL ASSISTANCE AGREEMENT

This Financial Assistance Agreement (the “Agreement”) is entered into as of August 13, 2026 (the “Execution Date”), with a retroactive effective date as of October 1, 2025 (“Effective Date”), by and among Berkshire Hathaway Specialty Insurance Company (“Berkshire”), Zurich American Insurance Company (“Zurich”), Hartford Fire Insurance Company, Euler Hermes North America, Markel Insurance Company (“Markel”), Western Surety Company, Federal Insurance Company (collectively referred to as “Sureties” and each as “Surety”), Southland Holdings, LLC (“Southland”), Southland Holdings, Inc. (the “Issuer”), Southland RE Properties LLC, Southland Contracting, Inc., Herita

…

Execution Version

SECOND AMENDMENT TO TERM LOAN AND SECURITY AGREEMENT

This SECOND AMENDMENT TO TERM LOAN AND SECURITY AGREEMENT (this “Amendment”) is entered into as of August 13, 2026, with a retroactive effective date as of March 17, 2026, by and among SOUTHLAND HOLDINGS LLC, a Texas limited liability company, as a Borrower, SOUTHLAND HOLDINGS, INC., a Delaware corporation, as a Guarantor, each other Guarantor party hereto, the lenders identified on the signature pages hereof (each such lender, together with its successors and permitted assigns, is referred to hereinafter as a “Lender”) and Alana Porrazzo, Esq. of Jennings, Haug, Kelcher, Mcleod Waterfall LLP, in her capacity as the Trustee of the Southland Collateral Trust, as agent for the Lenders (in such capacity, the “Agent”).

WITNESSETH:

…

July 24, 2026

Jason O’Byrne

EMAIL/DOCUSIGN

Re: Employment Agreement

Dear Jason,

Olema Pharmaceuticals, Inc. (the “Company”) is pleased to offer you employment as its Chief Financial Officer, pursuant to the terms of this offer letter agreement (the “Agreement”).

1.

Position; Duties. You will have overall responsibility for leading the Company’s finance organization and overseeing financial strategy, capital allocation, financial operations, corporate communications, investor relations, and related corporate functions, reporting directly to the Company’s Chief Executive Officer, working out of the Company’s San Francisco area office or at other locations as mutually agreed. You agree to devote your best efforts and full business time, skill and attention to the performance of your duties. You are also required to adhere to the general employment policies and practices of the Company that may be in effect from time to time, except that when the terms of this Agreement conflict with the Company’s general employment policies or practices, this Agreement will control. The Company

…